VAL-003

N/A

Report date: 2025/06/11 20:01:15

NME

Base Information

Drug NameVAL-003

Drug Alias Namekinase inhibitor (Dermira)ILK inhibitors (Valocor)integrin-linked kinase inhibitors (Valocor)kinase inhibitor (Valocor Therapeutics)QLT-450 +[7]

ClassificationSmall molecules

Mechanisms of ActionProtein kinases inhibitorsImmunomodulatorsMelanin stimulants

TargetsMelaninProtein kinases

Therapy Area/IndicationsVitiligo

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryCanadaUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesValocor Therapeutics Ltd

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesValocor Therapeutics Ltd Dermira Inc

Active IndicationsN/A

Inactive IndicationsVitiligo

Other Information

ATC CodeN/A